OTCMKTS:KNBWY

Kirin Q1 2025 Earnings Results & Report

Kirin logo
$19.61 -0.22 (-1.11%)
As of 01:44 PM Eastern

Kirin missed analyst expectations on both earnings and revenue in its Q1 2025 results, released May 13, 2025. The company reported EPS of $0.20 versus the $0.2126 consensus estimate, while revenue of $3.58 billion fell short of the $3.74 billion estimate by $163.72 million.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens

Kirin EPS Results

Actual EPS
$0.20
Consensus EPS
$0.2126
Beat/Miss
Missed by -$0.0126
One Year Ago EPS
N/A
EPS Beat Rate
4 of last 7 quarters

Kirin Revenue Results

Actual Revenue
$3.58 billion
Expected Revenue
$3.74 billion
Beat/Miss
Missed by -$163.72 million
YoY Revenue Growth
N/A

Conference Call Resources

Kirin Q1 2025 Earnings FAQ

Kirin (OTCMKTS:KNBWY) reported earnings of $0.20 per share for Q1 2025, missing the consensus estimate of $0.2126. The report was announced on Tuesday, May 13, 2025.

Kirin reported revenue of $3.58 billion for Q1 2025, against a consensus estimate of $3.74 billion.

Kirin Earnings Headlines

Your $7 scanner is waiting
The Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which stock, what price, and when to exit. The list reads the same whether you've traded for twenty years or twenty days, and it doesn't depend on account size. If it's not for you, refund the $7 and still keep the scanner for the full year. One payment, no re-bills.tc pixel
Kirin (KNBWY) Set to Announce Earnings on Tuesday
See More Kirin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kirin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kirin and other key companies, straight to your email.

About Kirin

Kirin (OTCMKTS:KNBWY) Holdings Company, Limited is a Japanese company with businesses in beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks and other nonalcoholic products, with brands sold in Japan and international markets.

The company traces its roots to the Japan Brewery Company, established in 1885, and adopted the Kirin Brewery name in 1907. Today, its pharmaceutical business includes Kyowa Kirin, which develops and sells medicines, while its health science activities include products such as supplements and functional foods.

Kirin is headquartered in Tokyo and serves customers across Japan and overseas, including markets in Asia-Pacific and other regions through its operating companies and businesses. Its portfolio spans consumer beverages as well as health-related products and medicines.

View Kirin Profile